{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:19:01Z","timestamp":1790533141549,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Acetaminophen is metabolized through a nontoxic sulfation and glucuronidation pathway and toxic oxidation pathway (via CYP2E1 and CYP1A2). A short-term high-fat diet induces alterations in the steatotic liver and may alter hepatic drug enzyme activity. In the case of acetaminophen, these alterations may result in an increased risk of hepatotoxicity. Therefore, this study was conducted to assess the effect of a 3-day hypercaloric high-fat diet on the plasma levels of acetaminophen metabolites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Nine healthy subjects participated in this randomized, crossover intervention study. The subjects consumed a regular diet or a regular diet supplemented with 500 mL of cream (1700 kcal) for 3 days and then fasted overnight. After ingesting 1000-mg acetaminophen, the plasma concentration of acetaminophen (APAP) and its metabolites [acetaminophen glucuronide, acetaminophen sulfate, 3-cysteinyl-acetaminophen, and 3-(N-acetyl-L-cystein-S-yl)-acetaminophen, and 3-methoxy-acetaminophen] were measured.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The 3-day high-fat diet increased the extrapolated area under the concentration\u2013time curve from 0 to infinity (area under the curve<jats:sub>0\u2013inf<\/jats:sub>) of APAP-Cys by approximately 20% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02) and that from 0 to 8 hours (area under the curve<jats:sub>0\u20138<\/jats:sub>) of APAP-Cys-NAC by approximately 39% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). The 3-day high-fat diet did not alter the pharmacokinetic parameters of the parent compound acetaminophen and other metabolites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>A short-term, hypercaloric, high-fat diet increases the plasma levels of the APAP metabolites formed by the oxidation pathway, which may increase the risk of hepatotoxicity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000993","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T23:00:06Z","timestamp":1651532406000},"page":"797-804","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Short-Term High-Fat Diet Alters Acetaminophen Metabolism in Healthy Individuals"],"prefix":"10.1097","volume":"44","author":[{"given":"Roos","family":"Achterbergh","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, OLVG, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen A.","family":"Lammers","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Kl\u00fcmpen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A. A.","family":"Math\u00f4t","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Amsterdam University Medical Centers, Amsterdam, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Romijn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm Res."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2036.2002.01224.x","article-title":"Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose","volume":"16","author":"Schi\u00f8dt","year":"2002","journal-title":"Aliment Pharmacol Ther."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003088-200342130-00001","article-title":"Dietary effects on drug metabolism and transport","volume":"42","author":"Harris","year":"2003","journal-title":"Clin Pharmacokinet."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1126\/science.1073502","article-title":"Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR","volume":"298","author":"Zhang","year":"2002","journal-title":"Science"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1210\/jc.2007-2524","article-title":"Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men","volume":"93","author":"van der Meer","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187569209788654005","article-title":"Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation","volume":"7","author":"Hernandez","year":"2009","journal-title":"Curr Pharmacogenomics Person Med."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1124\/dmd.110.035568","article-title":"Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism","volume":"38","author":"Gao","year":"2010","journal-title":"Drug Metab Dispos."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1124\/dmd.112.045112","article-title":"Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPAR\u03b1-, and Nrf2-null mice","volume":"40","author":"Aleksunes","year":"2012","journal-title":"Drug Metab Dispos."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/dmd.117.075655","article-title":"High-fat diet feeding alters expression of hepatic drug-metabolizing enzymes in mice","volume":"45","author":"Ning","year":"2017","journal-title":"Drug Metab Dispos."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/dmd.107.017731","article-title":"Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet","volume":"36","author":"Osabe","year":"2008","journal-title":"Drug Metab Dispos."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lfs.2011.05.005","article-title":"Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters","volume":"89","author":"Ghose","year":"2011","journal-title":"Life Sci."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/17425255.2016.1192126","article-title":"A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects","volume":"12","author":"Achterbergh","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MPG.0b013e3181f9b3a0","article-title":"Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease","volume":"52","author":"Barshop","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bcp.12802","article-title":"Can paracetamol (acetaminophen) be administered to patients with liver impairment?","volume":"81","author":"Hayward","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/15563650.2018.1487563","article-title":"Effects of nutritional status on acetaminophen measurement and exposure","volume":"57","author":"Achterbergh","year":"2019","journal-title":"Clin Toxicol (Phila)."},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cpt.541","article-title":"Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury","volume":"101","author":"Vliegenthart","year":"2017","journal-title":"Clin Pharmacol Ther."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/FTD.0000000000000373","article-title":"Quantitative method for simultaneous analysis of acetaminophen and 6 metabolites","volume":"39","author":"Lammers","year":"2017","journal-title":"Ther Drug Monit."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI89444","article-title":"Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance","volume":"127","author":"Hern\u00e1ndez","year":"2017","journal-title":"J Clin Invest."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.metabol.2013.01.011","article-title":"Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome?","volume":"62","author":"Jenko-Pra\u017enikar","year":"2013","journal-title":"Metabolism"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR)","volume":"100","author":"Huang","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40262-015-0357-0","article-title":"Morbidly obese patients exhibit increased CYP2E1-mediated oxidation of acetaminophen","volume":"55","author":"van Rongen","year":"2016","journal-title":"Clin Pharmacokinet."},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Holloway MG Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol Pharmacol."},{"issue":"suppl 1","key":"R27-20250603","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:11:59Z","timestamp":1748970719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000993","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"2021-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}